A Chinese manufacturer has been sent a warning letter by the US Food and Drug Administration after it emerged an …

Ask almost any pharmaceutical marketer where the future growth lies for the industry, and the answer will be almost certainly …
Sanofi-Aventis has partnered with China’s Minsheng Pharmaceuticals to establish a new consumer healthcare joint venture. Sanofi will take a majority …
Ranbaxy has shaken up its operations in China with the divestment of its stake a joint venture with Guangzhou Baiyunshan …
Pharmaceutical Product Development (PPD) has expanded its capacity to offer drug development services in Asia once again with the acquisition …

China’s allure for pharma companies continues unabated with Merck Serono’s opening of a research and development centre in Beijing. The …
GSK has joined with Chinese biotech Jiangsu Walvax to develop and manufacture paediatric vaccines for use in China.The pair will …
The Chinese government has announced it will cut the prices of more than 2,300 drugs by an average of 12% …
The European Directorate on the Quality of Medicines has suspended the certificates of suitability (CEPs) of four active pharmaceutical ingredients …
France's Sanofi-Aventis is planning a major capital investment programme in Beijing in a bid to bolster its position in the …
Bayer has furthered its R&D expansion in China with an agreement to form a joint pharmaceutical research centre with Tsinghua …
Bayer Schering Pharma's plan to build a 100 million-euro R&D centre in Beijing marks the company's first major foray into …
China's contract manufacturing organisation market was valued at more than $70 billion in 2007, with pharmaceuticals comfortably the largest contributor, …
AstraZeneca saw overall sales for the three months to September rise 3% to $7.8 billion. But growth in emerging markets …